Taizhou Science and Technology (Biological and Medical Industry) Commercial Innovation Base covers 20 square kilometers and has "one city and five zones" among which China Medical City (CMC) is the nuclear zone of the Base. Presently, there are more than 46 famous researching institutions and universities have entered CMC, such as California University QB3, Houston Medicine Center, Institute of Biophysics Chinese Academy Sciences, China Pharmaceutical University, Shenyang Pharmaceutical University, and Nanjing University. Some companies like US Epitomics Inc. formally entered CMC and many other 52 medicine manufacturing and serving enterprises entered CMC. The enterprises successively applied 108 productions including 6 kinds of international original drug, 31 kinds of new national Class I drug. More than half of the new drugs have been approved by national therapeutical authorities. Some projects, such as biology chip and ultrasound therapy apparatus, have already been put into manufacture. The Base has 5 functional branch zones as follows: scientific research development, manufacture, exhibition and trade, health and medical treatment, and matching service. The CMC has been focusing on the 5 platforms of medicine research and development, trade, manufacture, intellectual and information. Also, it has been actively providing 5 supporting service systems of the IP protection, undertaking financing, policy consultation, new medicine application, and information sharing. The Base has 3 post-doctoral research centers, 1 national science and technology service center, 1 national business technology development center, 1 national key laboratory, 3 provincial key research institutions, and 25 pharmaceutical research institutions. In the year 2007, the sales of the Base reached 20 billion Yuan.